Press releases

Welcome to the press section. If you want to be included in our media database, please send us an email.

Filter Press releases:

BRAIN Genome Editing, from discovery to the optimized organism
4 April 2022

Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

Read press release

Chairman of the Supervisory Board Dr. Georg Kellinghusen, CEO Adriaan Moelker and CFO Lukas Linnig (from left to right) during the digital Annual General Meeting for fiscal year 2020/21
9 March 2022

Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG

Read press release

23 February 2022

BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

Read press release

Mozzarella in Formo´s lab
8 February 2022

BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein

Read press release

Laboratory at AnalytiCon Discovery
2 February 2022

AnalytiCon Discovery and Pharvaris extend their collaboration

Read press release

1 February 2022

BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business

Read press release

Cover Annual Report 2020/21 BRAIN Biotech AG
17 January 2022

BRAIN Biotech AG publishes Annual Report for FY 2020/21

Read press release

11 January 2022

BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology

Read press release

8 December 2021

Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

Read press release

3 November 2021

BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms

Read press release

Share this page